It doesn't appear we have a plan at all...no company or product aqusitions and all co-promote opportunities have disappeared. We just launched two dogs into heavy generic markets, Myrbetriq and Astagraf-XL, and there is nothing of any value in our pipeline. There are no clinical trials being conducted on any of our drugs that add value and mounting concern over Xtandi. Where is this company going and why don't we have any leadership??? Seems like we are a $2.5 B titanic adrift at sea waiting to hit an iceberg.
Does anyone have a clue what our company strategy is?
Aucun commentaire:
Enregistrer un commentaire